OneSource Specialty Pharma gets EU-GMP renewal for Bengaluru facility
Unit II is a flagship integrated biologics drug-substance and drug-product manufacturing site with capabilities in drug-device combinations and sterile injectable products
OneSource Specialty Pharma has successfully received the renewal of the European Union Good Manufacturing Practices (EU-GMP) certification for its flagship Unit II manufacturing facility, located in Bengaluru, following an inspection conducted by a European regulatory authority.
Unit II is a flagship integrated biologics drug-substance and drug-product manufacturing site with capabilities in drug-device combinations and sterile injectable products.
OneSource Specialty Pharma is a multimodal specialty pharma CDMO with end-to-end capabilities across technology platforms and therapeutic modalities.
